Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Awwad, Mohamed H. S.; Kriegsmann, Katharina; Plaumann, Julian et al.
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myelomaONCOIMMUNOLOGY. Bd. 7. H. 10. 2018
Heitz, F.; Harter, P.; Kimmig, R. et al.
The prognostic value of tumor residuals (TR) indicated by surgeon (SA), by radiology (RA), or an integrated approach (IA) by surgeons' assessment and pre-chemotherapy CT-scan in patients with advanced ovarian cancer: An exploratory analysis of the AGO led Intergroup trial AGO-OVAR 12ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 12-12
Nault, Jean-Charles; Galle, Peter R.; Marquardt, Jens U.
The role of molecular enrichment on future therapies in hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 69. H. 1. 2018 S. 237-247
Hess, Georg
The role of stem cell transplantation in follicular lymphomaBEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. Bd. 31. H. 1. 2018 S. 31-40
Hagemann, Jan; Jacobi, Christian; Gstoettner, Sabine et al.
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell CarcinomaJOVE-JOURNAL OF VISUALIZED EXPERIMENTS. H. 134. 2018
Grimminger, Peter P.; Lang, Hauke
Totally Minimally Invasive Esophagectomy and Gastric Pull-Up Reconstruction with an Intrathoracic Circular Stapled Anastomosis with a Team of Two (Surgeon and Assistant Only)THORACIC AND CARDIOVASCULAR SURGEON. Bd. 66. H. 5. 2018 S. 401-403
Ogorodnikov, Anton; Levin, Michal; Tattikota, Surendra et al.
Transcriptome 3 ' end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastomaNATURE COMMUNICATIONS. Bd. 9. 2018
Witzel, I.; Laakmann, E.; Weide, R. et al.
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryEUROPEAN JOURNAL OF CANCER. Bd. 102. 2018 S. 1-9
Hirschfield, G.; Boudes, P.; Bowlus, C. et al.
Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 studyJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S105-S106
Dreyling, Martin; Aurer, Igor; Cortelazzo, Sergio et al.
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsLEUKEMIA & LYMPHOMA. Bd. 59. H. 8. 2018 S. 1814-1828